Booz Allen Hamilton
BAH
$77.07
-2.31%
Booz Allen Hamilton Holding Corporation is a technology and consulting firm that delivers artificial intelligence, cybersecurity, cloud integration, data platforms, and engineering solutions primarily to U.S. federal government agencies, alongside commercial and select international clients. The company occupies a distinctive position as an incumbent prime contractor in the government services arena, blending traditional management consulting with advanced technical capabilities that support defense missions and critical national infrastructure. The current investor narrative is dominated by the tension between Booz Allen's exposure to the Pentagon's accelerating AI and autonomous systems pivot — a potential long-term, high-margin tailwind — and near-term headwinds from a 6.4% year-over-year revenue decline in the most recent quarter and a stock that has fallen sharply from its highs. Recent headlines highlight a strong earnings beat that sent shares soaring in late July, with commentary framing the stock as trading at a steep discount to its historical valuation, while the broader defense sector benefits from programs like the Golden Dome missile shield initiative.…
BAH
Booz Allen Hamilton
$77.07
Related headlines
Investment Opinion: Should I buy BAH Today?
The synthesized recommendation is Hold, with a bias toward accumulating on weakness for patient investors. The core thesis is that BAH offers a compelling valuation discount (11.29x trailing PE, 0.86x PS) and strong free cash flow ($951 million TTM), but near-term revenue declines (-6.44% YoY) and cautious analyst sentiment (consensus 'hold', mean 2.87) warrant waiting for clearer signs of stabilization. The average analyst target of $85.15 implies +10.5% upside, but the wide range ($68–$140) reflects high uncertainty.
Supporting evidence for the Hold rating includes: (1) the deep valuation discount to historical multiples, with the PS ratio at 0.86x versus a historical range of 3.4–7.0x; (2) robust free cash flow of $951 million TTM, which comfortably covers the 2.87% dividend yield and $77 million in quarterly buybacks; (3) a low beta of 0.365, offering defensive characteristics; and (4) the potential for multiple expansion if the AI and defense pivot gains traction, as highlighted by the July earnings beat. However, these positives are offset by the 6.44% revenue decline, net margin of just 7.59%, and elevated debt-to-equity of 3.73x.
The biggest risks that could invalidate the thesis are a continued revenue decline beyond the current quarter, a further deterioration in margins, and a federal budget environment that reduces spending on consulting services. The rating would upgrade to Buy if revenue growth stabilizes or turns positive, or if the stock pulls back toward the $68–$70 range with improving fundamentals. It would downgrade to Sell if revenue declines accelerate below -10% YoY or if free cash flow deteriorates to the point of threatening the dividend. Relative to its history and peers, BAH appears undervalued on a cash flow and sales basis, but the market is pricing in legitimate concerns about growth and budget headwinds, making it fairly valued to slightly undervalued at current levels.
Sign up to view all
BAH 12-Month Price Forecast
The forward-looking view is neutral with medium confidence, balancing the deep valuation discount and strong cash flow against persistent revenue declines and budget uncertainty. The stock's 11.29x trailing PE and 0.86x PS ratio suggest the market has priced in significant pessimism, but the lack of a clear revenue inflection point keeps the risk/reward balanced. The AI and defense pivot offers a potential catalyst, but it is not yet reflected in financial results. I would upgrade to bullish if revenue growth turns positive or if the company announces major AI/defense contract wins, and downgrade to bearish if revenue declines accelerate or if free cash flow deteriorates to the point of threatening the dividend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booz Allen Hamilton's 12-month outlook, with a consensus price target around $85.15 and implied upside of +10.5% versus the current price.
Average Target
$85.15
0 analysts
Implied Upside
+10.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$68 - $140
Analyst target range
Thirteen analysts cover Booz Allen, with a consensus recommendation of "hold" and a recommendation mean of 2.87 (where 1 is Strong Buy and 5 is Strong Sell). The average price target is $85.15, implying approximately +10.5% upside from the current price of $77.07. The consensus leans neutral-to-cautious, with the distribution reflecting a market that sees limited near-term catalysts. Notably, the most recent institutional actions include a Goldman Sachs Sell rating maintained on 2026-07-14, JP Morgan Underweight maintained on 2026-05-26, and a Stifel upgrade from Hold to Buy on 2026-05-26 — suggesting a split between bears focused on budget headwinds and bulls attracted by the valuation discount.
The target price range is exceptionally wide, spanning from a low of $68.00 to a high of $140.00 — a spread of more than 2x between the most bearish and most bullish views. The low target of $68 implies roughly -11.8% downside and likely prices in continued revenue declines, margin compression, and a prolonged federal budget impasse. The high target of $140 implies +81.7% upside and assumes a successful pivot toward AI and defense technology contracts, multiple expansion back toward historical norms, and a resolution of near-term budget uncertainty. This unusually wide spread signals high uncertainty and low analyst conviction, which is consistent with the "hold" consensus and the stock's elevated short ratio of 4.45 days. The estimated EPS average of $7.40 for the forward year, against a forward PE of 11.43x, suggests that even the bullish analysts are not projecting aggressive earnings growth — the upside case rests more on multiple re-rating than on fundamental acceleration.
Drowning in data?
Find the real signal!
Bulls vs Bears: BAH Investment Factors
The bear case currently has stronger near-term evidence, anchored by a 6.44% year-over-year revenue decline, margin compression, and a stock that has underperformed the S&P 500 by nearly 39 percentage points over the past year. However, the bull case rests on a compelling valuation argument: at 11.29x trailing earnings and 0.86x sales, BAH trades near the bottom of its historical range, and the $951 million in trailing free cash flow provides a solid foundation for the dividend and buyback program. The single most important tension is whether the revenue decline is a temporary air pocket tied to federal budget timing or the beginning of a structural slowdown in government consulting demand. If the Pentagon's AI and autonomous systems pivot translates into meaningful contract wins for BAH, the stock could re-rate sharply toward its historical multiples; if budget pressures persist, the valuation discount could prove to be a value trap.
Bullish
- Deep valuation discount to history: BAH trades at a trailing PE of 11.29x and forward PE of 11.43x, near the bottom of its historical 11.5x–37x range and well below the 15–22x it commanded during 2021–2024. The PS ratio of 0.86x is dramatically below the 3.4–7.0x range seen from 2021 through early 2026, implying the market has already priced in a severe earnings and sentiment reset.
- Strong free cash flow and capital returns: Trailing twelve-month free cash flow is $951 million, comfortably covering $77 million in quarterly buybacks and $71 million in dividends. The 2.87% dividend yield and 32.4% payout ratio signal a shareholder-friendly capital allocation policy even amid revenue headwinds.
- Analyst target implies upside: The average analyst price target of $85.15 implies roughly +10.5% upside from the current $77.07, and the high target of $140 implies +81.7% upside. The wide target range ($68–$140) reflects high uncertainty but also meaningful optionality if the AI/defense pivot materializes.
- Low beta defensive profile: With a beta of 0.365, BAH is roughly 64% less volatile than the broader market, making it an attractive defensive holding in a risk-off environment. This low correlation to market swings may appeal to income and capital-preservation oriented portfolios.
Bearish
- Revenue contraction accelerating: Most recent quarterly revenue of $2.783 billion declined 6.44% year-over-year from $2.974 billion, with sequential declines from $2.890 billion in Q2 to $2.620 billion in Q3. This negative trajectory marks a sharp reversal from the steady growth BAH historically delivered and raises concerns about structural budget pressures.
- Margin compression and earnings decline: Net income fell to $205 million in the most recent quarter from $269 million in the prior-year Q1, with net margin at just 7.59%. Operating margin of 9.75% and EBITDA margin of 11.35% are thin for a consulting firm, and the labor-intensive, cost-reimbursable contract mix limits margin upside.
- Elevated leverage constrains flexibility: Debt-to-equity stands at 3.73x and total debt-to-capitalization at 78.86%, leaving limited financial flexibility if revenue declines persist. While interest coverage of 5.48x is adequate, the high debt load amplifies risk during a downturn and limits strategic investment capacity.
- Analyst consensus cautious with sell ratings: The consensus recommendation is 'hold' with a mean of 2.87, and recent institutional actions include Goldman Sachs maintaining a Sell rating and JP Morgan maintaining Underweight. This split reflects legitimate concerns about federal budget headwinds and the sustainability of the revenue base.
BAH Technical Analysis
Booz Allen is in a sustained downtrend that has recently transitioned into a volatile recovery attempt. The stock is down 23.85% over the past year, a stark underperformance versus the S&P 500's +15.01% gain, leaving a relative strength gap of -38.86 percentage points. At the current price of $77.07, the stock sits at roughly 35.4% of its 52-week range (low of $59.50, high of $109.10), positioning it in the lower-middle portion of its annual band — not a fresh low, but far from the momentum-driven highs that would signal overextension. This positioning suggests a market that has already priced in significant pessimism but has not yet confirmed a durable trend reversal.
Short-term momentum is mixed and diverging from the longer-term trend. The stock has gained 16.14% over the past three months, a sharp rebound from the June lows near $59.71, yet it is down 2.25% over the past month and -3.60% over six months. This divergence — a strong 3-month bounce against a negative 1-month drift — signals that the initial recovery impulse is losing steam and the stock may be consolidating or forming a lower high. Relative strength versus SPY is +14.14 points over three months but -1.29 points over one month, confirming that the recent outperformance is fading. The 1-month decline of 2.25% compares unfavorably to SPY's -0.96%, indicating the stock is now lagging the market on a near-term basis.
Key technical levels are well-defined. Support rests at the 52-week low of $59.50, which also aligns with the June capitulation zone around $59.71; a breakdown below this level would signal a resumption of the primary downtrend and likely target new lows. Resistance sits at the 52-week high of $109.10, though the more immediate hurdle is the $80-$84 zone where the stock repeatedly failed in April and June. A breakout above $84 would suggest a genuine trend change, while failure to hold $70 would reinforce the bearish structure. The stock's beta of 0.365 is remarkably low, indicating it is roughly 64% less volatile than the broader market — a defensive characteristic that may appeal to risk-averse investors but also means the stock lacks the high-beta torque that drives sharp rallies in risk-on environments. The maximum drawdown of -46.1% over the period underscores that low beta has not protected against severe idiosyncratic selling pressure.
Beta
0.36
0.36x market volatility
Max Drawdown
-46.1%
Largest decline past year
52-Week Range
$60-$109
Price range past year
Annual Return
-23.9%
Cumulative gain past year
| Period | BAH Return | S&P 500 |
|---|---|---|
| 1m | -2.2% | -0.5% |
| 3m | +16.1% | +2.3% |
| 6m | -3.6% | +16.6% |
| 1y | -23.9% | +14.8% |
| ytd | -9.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAH Fundamental Analysis
Booz Allen's revenue trajectory has turned negative, a notable shift for a company long viewed as a steady government-services compounder. The most recent quarter (ending 2026-03-31) reported revenue of $2.783 billion, down 6.44% year-over-year from $2.974 billion in the prior-year period. Sequentially, revenue declined from $2.890 billion in Q2 to $2.620 billion in Q3 and then to $2.783 billion in Q4, showing no clear stabilization. The revenue mix is heavily weighted toward cost-reimbursable contracts at $1.601 billion, followed by time-and-materials at $632 million and fixed-price at $550 million — a structure that provides revenue visibility but limits margin upside when costs are passed through. The YoY decline implies either contract timing shifts, budget uncertainty, or competitive pressure, and the investment case now hinges on whether this is a temporary air pocket or the start of a structural slowdown.
Profitability remains intact but is under pressure. The company reported net income of $205 million in the most recent quarter, with a net margin of 7.59% and a gross margin of 20.91%. The gross margin has compressed from 53.6% in the year-ago quarter (as reported) to 20.88%, though this comparison is distorted by inconsistent cost-of-revenue classification across periods. Operating margin stands at 9.75%, and EBITDA for the quarter was $316 million, representing an EBITDA margin of 11.35%. The company is solidly profitable, but the margin trend is not expanding — net income of $205 million was down from $269 million in the prior-year Q1, and the 7.59% net margin is thin for a consulting firm, reflecting the labor-intensive, low-margin nature of government services work.
Balance sheet and cash flow metrics reveal a leveraged but cash-generative business. Debt-to-equity is elevated at 3.73x, and the company carries significant long-term debt, with total debt-to-capitalization at 78.86%. However, free cash flow remains robust at $951 million on a trailing twelve-month basis, and the current ratio of 1.78 indicates adequate short-term liquidity. Return on equity is exceptionally high at 77.01%, though this is amplified by the leveraged capital structure rather than pure operational excellence. The interest coverage ratio of 5.48x provides a reasonable cushion, and the company returned capital aggressively through $77 million in stock repurchases and $71 million in dividends in the most recent quarter. The key risk is that the high debt load limits financial flexibility if revenue declines persist, but for now, the cash generation comfortably covers debt service and shareholder returns.
Quarterly Revenue
$2.8B
2026-03
Revenue YoY Growth
-6.4%
YoY Comparison
Gross Margin
20.9%
Latest Quarter
Free Cash Flow
$951000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAH Overvalued?
Because Booz Allen is profitable — with trailing net income positive and EPS of $0.088 on a per-share basis (though this appears to reflect a quarterly figure) — the PE ratio is the appropriate primary valuation metric. The trailing PE stands at 11.29x, while the forward PE is 11.43x, an unusual configuration where the forward multiple is slightly higher than the trailing, implying the market expects flat-to-slightly-lower earnings ahead. This narrow gap suggests the market is not pricing in meaningful earnings growth, consistent with the negative revenue trend and cautious analyst estimates. The PEG ratio of -2.22 is negative and therefore not meaningful, reflecting the earnings decline rather than a growth-adjusted valuation signal.
Relative to the broader Industrials sector and consulting services peers, Booz Allen screens as deeply discounted. The company trades at a price-to-sales ratio of just 0.86x and an EV/Sales of 1.18x, with an EV/EBITDA of 10.51x. These are low absolute multiples for a business with a 7.59% net margin and 9.75% operating margin. The price-to-book ratio of 8.70x appears high, but this is a function of the leveraged balance sheet and low book equity rather than a premium valuation. Compared to typical government services peers that often trade at 12-16x forward earnings, Booz Allen's 11.43x forward PE represents a discount of roughly 10-30%, which the market appears to justify through revenue contraction and policy uncertainty rather than any fundamental deterioration in competitive position.
Historically, Booz Allen has traded at significantly higher multiples. The historical ratios data shows PE ratios ranging from 11.5x to over 37x over the past several years, with the stock consistently commanding 15-22x earnings during 2021-2024. The current trailing PE of 11.29x is near the bottom of that historical band, and the PS ratio of 0.86x is dramatically below the 3.4-7.0x range seen from 2021 through early 2026. This compression reflects the market's sharp de-rating of the stock amid revenue declines and federal budget uncertainty. The critical question is whether this represents a genuine value opportunity — as the July earnings-beat commentary suggested — or a value trap if government spending on consulting services continues to face pressure.
PE
11.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant given the company's leveraged balance sheet and declining revenue. Debt-to-equity of 3.73x and total debt-to-capitalization of 78.86% mean that a prolonged revenue downturn could strain interest coverage, which currently stands at 5.48x. The 6.44% year-over-year revenue decline, with sequential drops from $2.890 billion in Q2 to $2.620 billion in Q3, raises the risk that fixed costs and debt service become a larger burden relative to a shrinking top line. Additionally, the cost-reimbursable contract structure ($1.601 billion of the mix) limits margin expansion, and net margin of 7.59% leaves little cushion if contract timing shifts or competition intensifies.
Market and competitive risks center on valuation compression and sector rotation. While BAH's 11.29x trailing PE is low relative to its own history, the market may continue to apply a discount if revenue growth remains negative, and the forward PE of 11.43x being slightly above the trailing PE suggests the market expects flat-to-lower earnings ahead. The stock's beta of 0.365 indicates low correlation to broad market moves, but this defensive characteristic has not prevented a -46.1% maximum drawdown, highlighting idiosyncratic risk. Competitive pressures from both traditional defense contractors and non-traditional tech entrants bidding for AI and cybersecurity work could erode BAH's incumbency advantage, and any shift in federal budget priorities away from consulting services would be a direct headwind.
In a worst-case scenario, a continued federal budget impasse or a shift in Pentagon spending away from consulting services could drive revenue declines beyond the current 6.44% rate, forcing earnings estimates lower and potentially pressuring the dividend. If the stock breaks below its 52-week low of $59.50, the next support level is unclear, and the analyst low target of $68 implies roughly -11.8% downside from the current $77.07. A more severe scenario, such as a recession or a sharp reduction in defense discretionary spending, could push the stock toward the $59.50 low, representing a decline of approximately -22.8% from current levels. Investors should be prepared for the possibility of a further 20–25% drawdown if the revenue trajectory does not stabilize.
FAQ
The key risks for BAH are ranked as follows: First, financial risk from high leverage, with debt-to-equity at 3.73x and total debt-to-capitalization at 78.86%, which limits flexibility if revenue declines persist. Second, operational risk from the 6.44% year-over-year revenue decline and thin net margin of 7.59%, which could lead to earnings misses and further estimate cuts. Third, competitive and market risk from potential loss of market share to non-traditional defense contractors and the risk of multiple compression if the stock remains out of favor. Fourth, macro and policy risk from federal budget uncertainty, as the company derives the vast majority of revenue from U.S. government agencies, making it highly sensitive to changes in defense and discretionary spending priorities.
The 12-month forecast for BAH includes three scenarios. The base case (50% probability) targets $80–$90, assuming revenue stabilizes and the stock re-rates modestly toward the analyst average of $85.15. The bull case (25% probability) targets $110–$140, driven by successful AI and defense contract wins and multiple expansion back toward historical norms. The bear case (25% probability) targets $59.50–$68, assuming continued revenue declines and budget pressures push the stock below its 52-week low. The most likely scenario is the base case, with the key assumption being that the revenue decline moderates and free cash flow remains above $900 million, supporting the dividend and buyback program. However, the wide target range ($68–$140) reflects high uncertainty and low analyst conviction.
BAH appears undervalued relative to its own history and peers. The trailing PE of 11.29x is near the bottom of its historical range (11.5x–37x), and the PS ratio of 0.86x is dramatically below the 3.4–7.0x range seen from 2021 through early 2026. Compared to government services peers that often trade at 12–16x forward earnings, BAH's forward PE of 11.43x represents a discount of roughly 10–30%. The market is pricing in continued revenue declines and budget uncertainty, as evidenced by the negative PEG ratio and the forward PE being slightly above the trailing PE. If the company can stabilize revenue and demonstrate progress on its AI and defense initiatives, the multiple could expand toward historical norms, implying significant upside. However, the discount may be justified if the revenue decline proves structural rather than cyclical.
From a risk/reward perspective, BAH presents a mixed picture. The stock trades at a deep discount to its historical valuation (11.29x trailing PE vs. a historical range of 11.5x–37x) and offers a 2.87% dividend yield with strong free cash flow of $951 million TTM. However, revenue declined 6.44% year-over-year in the most recent quarter, and the analyst consensus is hold with a mean of 2.87, reflecting legitimate concerns about federal budget headwinds. The average target of $85.15 implies +10.5% upside, but the downside risk to the 52-week low of $59.50 is approximately -22.8%. For value-oriented investors with a long time horizon and tolerance for volatility, BAH could be a good buy on further weakness, but near-term catalysts are limited and the revenue trajectory needs to stabilize first.
BAH is more suitable for long-term investment than short-term trading. The stock's low beta of 0.365 indicates it is roughly 64% less volatile than the broader market, which limits the potential for sharp short-term rallies but also provides downside protection. The 2.87% dividend yield and consistent free cash flow generation make it attractive for income-focused, long-term investors. However, the current revenue decline and budget uncertainty mean that near-term earnings visibility is low, and the stock could remain range-bound or drift lower until there is a clear inflection. A suggested minimum holding period is 2–3 years to allow for the AI and defense pivot to materialize and for the valuation discount to potentially close. Short-term traders may find limited opportunities given the low beta and lack of near-term catalysts.
